Tech Company Financing Transactions

Exonics Therapeutics Funding Round

Exonics Therapeutics, operating out of Cambridge, scored $5 million from CureDuchenne Ventures.

Transaction Overview

Announced On
2/28/2017
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Investors

CureDuchenne Ventures (Debra Miller)

Proceeds Purpose
The initial seed funding will allow Exonics to advance the preclinical research of its scientific founder and chief science advisor Eric Olson, PhD.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Email Address
Overview
At Exonics Therapeutics, our mission is to permanently correct genetic mutations resulting in neuromuscular diseases like Duchenne muscular dystrophy. Duchenne is a devastating muscle disease in children, primarily boys, caused by the absence of dystrophin.
Profile
Exonics Therapeutics LinkedIn Company Profile
Social Media
Exonics Therapeutics Company Twitter Account
Company News
Exonics Therapeutics News
Facebook
Exonics Therapeutics on Facebook
YouTube
Exonics Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Ripple
  John Ripple LinkedIn Profile  John Ripple Twitter Account  John Ripple News  John Ripple on Facebook
Chief Scientific Officer
Eric Olson
  Eric Olson LinkedIn Profile  Eric Olson Twitter Account  Eric Olson News  Eric Olson on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/28/2017: SynGen venture capital transaction
Next: 2/28/2017: Voicera venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record tech company VC transactions. VC transactions on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary